HIV Self Test Factsheet
Atomo Diagnostics’ blood-based rapid diagnostic test (RDT) for HIV screening, acclaimed internationally for its innovative design, superior performance, and user-friendly nature, is a ground-breaking test that is distinguished as the only HIV Self Test included on the Australian Register of Therapeutic Goods (ARTG 311989).
Contrary to traditional clinical testing methodologies, the Atomo HIV Self Test offers the distinct advantage of delivering results within a mere 15 minutes. Its design excellence is further underscored by its accuracy, boasting specificity and sensitivity levels of 99.6%. This precision is achieved through carefully designed interlocked steps, facilitating ease of use by individuals with no medical background in a private and confidential manner.
Understanding the importance of accessibility to information, Atomo Diagnostics has compiled a list of frequently asked questions regarding our HIV Self Test, which has been distilled into an informative factsheet designed for easy comprehension and quick reference. This factsheet serves as an invaluable resource for individuals seeking detailed insights into the test's features, usage, and reliability of the test.
Our aim is to enhance the standards of self-testing, making reliable, efficient, and discreet testing more accessible to individuals worldwide, thereby contributing to the broader public health effort in managing and preventing the spread of HIV. We invite you to access this comprehensive guide by completing the submission form provided below.
Request A Copy of the Atomo Diagnostics HIV Self Test Factsheet
